Market by Test Type, Treatment, and Country Outlook | Forecast 2023-2030
Triton’s report suggests that the male infertility market in Europe is estimated to register revenue growth at a CAGR of 4.59% during the forecast years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries evaluated in the region consist of:
•
United Kingdom
•
Germany
•
France
•
Spain
•
Italy
• Poland
•
Rest of Europe
The Europe male
infertility market’s growth is projected to be prompted by factors such as
increased affordability of therapies and devices, wider adoption of assisted
reproductive technologies, and the availability of reimbursement coverages. The
presence of prominent market players, including Bayer AG and Merck, have
elevated the scope of male infertility treatments. These companies' research
and development investments, coupled with a large patient base and approvals
from the European Medicines Agency (EMA), are expected to significantly boost
the market’s growth in Europe during the forecast period.
Germany holds the highest share in the male infertility market. In recent years, changes in diet, lifestyle, and pollution levels have led to a significant increase in cases of reduced sperm count. This has led to a rise in male infertility treatments, along with R&D activities. As per industry sources, the smoking rate among German men is around 34.1%. Cigarette smoking has proven to have harmful effects on male fertility, further increasing the number of infertility cases among men. Hence, these factors contribute heavily to the male infertility market’s expansion.
Male infertility can be
detected via the DNA fragmentation technique, which identifies changes in
nucleotide composition or physical breaks in one or both sperm chromosomes.
Research indicates that infertile males often exhibit sperm DNA damage, leading
to unfavorable reproductive outcomes. The DNA fragmentation approach holds
potential as a novel method to assess fertility. Consequently, in specific
clinical scenarios, sperm DNA fragmentation (SDF) tests serve as complementary
assessments to traditional semen analysis.
The
market’s growth is assessed based on test type and treatment.
Based on test type, it is sectioned into DNA fragmentation technique,
microscopic examination, sperm agglutination, computer-assisted semen analysis,
oxidative stress analysis, sperm penetration assay, and other test types.
The prominent companies listed in
the market include Halotech DNA, EMD Serono Inc, Endo International Plc,
Vitrolife, and Bayer AG.
Bayer AG operates via three business segments, namely, crop
science, pharmaceuticals, and consumer health. The
Consumer Health division covers dermatology, nutritional supplements, pain and
cardiovascular risk prevention, digestive health, allergy, infertility, and
cough and cold treatments. It provides a range of nonprescription
over-the-counter medications, medical items, cosmetics, and self-care
solutions. Further, the pharmaceuticals division specializes in oncology,
hematology, ophthalmology pharmaceuticals, etc. It also offers diagnostic
imaging equipment and contrast agents. Globally, Bayer AG operates across 83
countries, with headquarters in Germany.
Key deliverables of the report:
· Market CAGR during the forecasting
years 2023-2030
· Detailed data highlighting key
insights, industry components, and market strategies
· Comprehensive information and
estimation of the male infertility market revenue growth in Europe and its
influence on the parent market
· In-depth study of forthcoming trends
in consumer behavioral patterns
· A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
· A wide-ranging study of factors that
will challenge the Europe male infertility market’s growth during the upcoming
years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
MALE INFERTILITY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PARENT
MARKET ANALYSIS
2.2. IMPACT
ANALYSIS ON THE MALE INFERTILITY MARKET
2.2.1. COVID-19
IMPACT
2.2.2. UKRAINE-RUSSIA
WAR IMPACT
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
MATURITY ANALYSIS
2.5. KEY
MARKET STRATEGIES
2.5.1. COLLABORATIONS
2.5.2. PRODUCT
LAUNCHES
2.5.3. MERGERS
& ACQUISITIONS
2.5.4. BUSINESS
DIVESTITURES & EXPANSIONS
2.6. MARKET
DRIVERS
2.6.1. PREVALENCE
OF INFERTILITY
2.6.2. USE OF
ASSISTED REPRODUCTIVE TECHNOLOGIES
2.6.3. TECHNOLOGICAL
INNOVATIONS AND ADVANCEMENTS
2.7. MARKET
CHALLENGE
2.7.1. HIGH COST
OF TREATMENT
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
ACCEPTANCE OF MINIMALLY INVASIVE SURGERIES
2.8.2. GROWING
AVAILABILITY OF INFERTILITY TREATMENT DRUGS, PROCEDURES, AND DEVICES
2.8.3. GOVERNMENT
INITIATIVES TOWARD IMPROVING REIMBURSEMENT POLICIES
2.9. ANALYST
PERSPECTIVE
3. EUROPE
MALE INFERTILITY MARKET – BY TEST TYPE
3.1. DNA
FRAGMENTATION TECHNIQUE
3.2. OXIDATIVE
STRESS ANALYSIS
3.3. MICROSCOPIC
EXAMINATION
3.4. SPERM
AGGLUTINATION
3.5. COMPUTER-ASSISTED
SEMEN ANALYSIS
3.6. SPERM
PENETRATION ASSAY
3.7. OTHER
TEST TYPES
4. EUROPE
MALE INFERTILITY MARKET – BY TREATMENT
4.1. ASSISTED
REPRODUCTIVE TECHNOLOGY AND SURGERY
4.2. MEDICATIONS
5. EUROPE
MALE INFERTILITY MARKET – BY COUNTRY OUTLOOK
5.1. COUNTRY
ANALYSIS
5.1.1. UNITED
KINGDOM
5.1.1.1. UNITED
KINGDOM MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.1.2. GERMANY
5.1.2.1. GERMANY
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.1.3. FRANCE
5.1.3.1. FRANCE
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.1.4. ITALY
5.1.4.1. ITALY
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.1.5. SPAIN
5.1.5.1. SPAIN
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.1.6. POLAND
5.1.6.1. POLAND
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.1.7. REST
OF EUROPE
5.1.7.1. REST
OF EUROPE MALE INFERTILITY MARKET FORECAST & PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. HALOTECH
DNA
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.2. EMD
SERONO INC
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ENDO
INTERNATIONAL PLC
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY
CHALLENGES
6.4. VITROLIFE
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. BAYER AG
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. AYTU
BIOPHARMA
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY
CHALLENGES
6.7. ZYDUS
LIFESCIENCES LIMITED
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.7.3. KEY
STRENGTHS
6.7.4. KEY
CHALLENGES
6.8. CINNAGEN
CO
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. SANOFI
SA
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. LABORATORY
CORPORATION OF AMERICA HOLDINGS
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
6.10.3. KEY STRENGTHS
6.10.4. KEY
CHALLENGES
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE
1: EUROPE MALE INFERTILITY MARKET, BY
COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
2: LIST OF COLLABORATIONS
TABLE
3: LIST OF PRODUCT LAUNCHES
TABLE
4: LIST OF MERGERS & ACQUISITIONS
TABLE
5: LIST OF BUSINESS DIVESTITURES &
EXPANSIONS
TABLE
6: EUROPE MALE INFERTILITY MARKET, BY
TEST TYPE, 2023-2030 (IN $ MILLION)
TABLE
7: EUROPE MALE INFERTILITY MARKET, BY TREATMENT,
2023-2030 (IN $ MILLION)
TABLE
8: EUROPE MALE INFERTILITY MARKET, BY
COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE
1: MARKET MATURITY ANALYSIS
FIGURE
2: EUROPE MALE INFERTILITY MARKET, BY
TYPE, 2022 & 2030 (IN %)
FIGURE
3: EUROPE MALE INFERTILITY MARKET, BY
DNA FRAGMENTATION TECHNIQUE, 2023-2030 (IN $ MILLION)
FIGURE
4: EUROPE MALE INFERTILITY MARKET, BY
OXIDATIVE STRESS ANALYSIS, 2023-2030 (IN $ MILLION)
FIGURE
5: EUROPE MALE INFERTILITY MARKET, BY
MICROSCOPIC EXAMINATION, 2023-2030 (IN $ MILLION)
FIGURE
6: EUROPE MALE INFERTILITY MARKET, BY
SPERM AGGLUTINATION, 2023-2030 (IN $ MILLION)
FIGURE
7: EUROPE MALE INFERTILITY MARKET, BY
COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2030 (IN $ MILLION)
FIGURE
8: EUROPE MALE INFERTILITY MARKET, BY
SPERM PENETRATION ASSAY, 2023-2030 (IN $ MILLION)
FIGURE
9: EUROPE MALE INFERTILITY MARKET, BY
OTHER TEST TYPES, 2023-2030 (IN $ MILLION)
FIGURE
10: EUROPE MALE INFERTILITY MARKET, BY
TREATMENT, 2022 & 2030 (IN %)
FIGURE
11: EUROPE MALE INFERTILITY MARKET, BY
ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2030 (IN $ MILLION)
FIGURE
12: EUROPE MALE INFERTILITY MARKET, BY
MEDICATIONS, 2023-2030 (IN $ MILLION)
FIGURE
13: EUROPE MALE INFERTILITY MARKET, BY
COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE
14: UNITED KINGDOM MALE INFERTILITY
MARKET 2023-2030 (IN $ MILLION)
FIGURE
15: GERMANY MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
16: FRANCE MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
17: ITALY MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
18: SPAIN MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
19: POLAND MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
20: REST OF EUROPE MALE INFERTILITY
MARKET 2023-2030 (IN $ MILLION)